Пожалуйста, используйте этот идентификатор, чтобы цитировать или ссылаться на этот ресурс: http://elar.urfu.ru/handle/10995/111134
Полная запись метаданных
Поле DCЗначениеЯзык
dc.contributor.authorStrekalova, T.en
dc.contributor.authorSvirin, E.en
dc.contributor.authorWaider, J.en
dc.contributor.authorGorlova, A.en
dc.contributor.authorCespuglio, R.en
dc.contributor.authorKalueff, A.en
dc.contributor.authorPomytkin, I.en
dc.contributor.authorSchmitt-Boehrer, A. G.en
dc.contributor.authorLesch, K. -P.en
dc.contributor.authorAnthony, D. C.en
dc.date.accessioned2022-05-12T08:13:30Z-
dc.date.available2022-05-12T08:13:30Z-
dc.date.issued2021-
dc.identifier.citationAltered Behaviour, Dopamine and Norepinephrine Regulation in Stressed Mice Heterozygous in TPH2 Gene / T. Strekalova, E. Svirin, J. Waider et al. // Progress in Neuro-Psychopharmacology and Biological Psychiatry. — 2021. — Vol. 108. — 110155.en
dc.identifier.issn0278-5846-
dc.identifier.otherAll Open Access, Hybrid Gold3
dc.identifier.urihttp://elar.urfu.ru/handle/10995/111134-
dc.description.abstractGene-environment interaction (GxE) determines the vulnerability of an individual to a spectrum of stress-related neuropsychiatric disorders. Increased impulsivity, excessive aggression, and other behavioural characteristics are associated with variants within the tryptophan hydroxylase-2 (Tph2) gene, a key enzyme in brain serotonin synthesis. This phenotype is recapitulated in naïve mice with complete, but not with partial Tph2 inactivation. Tph2 haploinsufficiency in animals reflects allelic variation of Tph2 facilitating the elucidation of respective GxE mechanisms. Recently, we showed excessive aggression and altered serotonin brain metabolism in heterozygous Tph2-deficient male mice (Tph2+/−) after predator stress exposure. Here, we sought to extend these studies by investigating aggressive and anxiety-like behaviours, sociability, and the brain metabolism of dopamine and noradrenaline. Separately, Tph2+/− mice were examined for exploration activity in a novel environment and for the potentiation of helplessness in the modified swim test (ModFST). Predation stress procedure increased measures of aggression, dominancy, and suppressed sociability in Tph2+/− mice, which was the opposite of that observed in control mice. Anxiety-like behaviour was unaltered in the mutants and elevated in controls. Tph2+/− mice exposed to environmental novelty or to the ModFST exhibited increased novelty exploration and no increase in floating behaviour compared to controls, which is suggestive of resilience to stress and despair. High-performance liquid chromatography (HPLC) revealed significant genotype-dependent differences in the metabolism of dopamine, and norepinephrine within the brain tissue. In conclusion, environmentally challenged Tph2+/− mice exhibit behaviours that resemble the behaviour of non-stressed null mutants, which reveals how GxE interaction studies can unmask latent genetically determined predispositions. © 2020 The Authors.en
dc.description.sponsorshipThe authors' work reported here was supported by Deutsche Forschungsgemeinschaft (DFG:CRC TRR58A1/A5), DAAD (to ES), the European Union's Seventh Framework Programme (FP7/2007–2013) under Grant No.602805 (Aggressotype) and the Horizon 2020 Research and Innovation Programme under Grant No.728018 (Eat2beNICE) (to KPL and TS) and the President's program of PhD Exchange of RF-2017 (to TS and DA). We appreciate the valuable technical help of Natalia Bazhenova, Drs. Alexander Trofimov and Natalia Markova with this project.en
dc.format.mimetypeapplication/pdfen
dc.language.isoenen
dc.publisherElsevier Inc.en1
dc.publisherElsevier BVen
dc.rightsinfo:eu-repo/semantics/openAccessen
dc.sourceProg. Neuro-Psychopharmacol. Biol. Psychiatry2
dc.sourceProgress in Neuro-Psychopharmacology and Biological Psychiatryen
dc.subjectAGGRESSIONen
dc.subjectDOPAMINEen
dc.subjectMOUSEen
dc.subjectNORADRENALINEen
dc.subjectSTRESSen
dc.subjectTRYPTOPHAN HYDROXYLASE-2 (TPH2)en
dc.subjectDOPAMINEen
dc.subjectNORADRENALINen
dc.subjectPENTOBARBITALen
dc.subjectSEROTONINen
dc.subjectSODIUM CHLORIDEen
dc.subjectTRYPTOPHAN HYDROXYLASE 2en
dc.subjectDOPAMINEen
dc.subjectNORADRENALINen
dc.subjectTPH2 PROTEIN, MOUSEen
dc.subjectTRYPTOPHAN HYDROXYLASEen
dc.subjectAGGRESSIONen
dc.subjectAMYGDALAen
dc.subjectANESTHESIAen
dc.subjectANIMAL EXPERIMENTen
dc.subjectANIMAL MODELen
dc.subjectANTIDEPRESSANT ACTIVITYen
dc.subjectARTICLEen
dc.subjectBEHAVIORen
dc.subjectBODY MOVEMENTen
dc.subjectBRAIN CORTEXen
dc.subjectCONTROLLED STUDYen
dc.subjectCORPUS STRIATUMen
dc.subjectDOPAMINE METABOLISMen
dc.subjectELECTROCHEMISTRYen
dc.subjectEXPERIMENTAL BEHAVIORAL TESTen
dc.subjectGENOTYPEen
dc.subjectGENOTYPE ENVIRONMENT INTERACTIONen
dc.subjectHAPLOINSUFFICIENCYen
dc.subjectHEAD MOVEMENTen
dc.subjectHETEROZYGOTEen
dc.subjectHIGH PERFORMANCE LIQUID CHROMATOGRAPHYen
dc.subjectHIPPOCAMPUSen
dc.subjectILLUMINATIONen
dc.subjectIMMUNOREACTIVITYen
dc.subjectIMPULSIVENESSen
dc.subjectMALEen
dc.subjectMENTAL DISEASEen
dc.subjectMETABOLISMen
dc.subjectNONHUMANen
dc.subjectPHENOTYPEen
dc.subjectPHYSIOLOGICAL STRESSen
dc.subjectPREDATIONen
dc.subjectRATen
dc.subjectANIMALen
dc.subjectGENETICSen
dc.subjectMENTAL STRESSen
dc.subjectPSYCHOLOGYen
dc.subjectSOCIAL BEHAVIORen
dc.subjectTRANSGENIC MOUSEen
dc.subjectWISTAR RATen
dc.subjectANIMALSen
dc.subjectBRAINen
dc.subjectDOPAMINEen
dc.subjectMICEen
dc.subjectMICE, TRANSGENICen
dc.subjectNOREPINEPHRINEen
dc.subjectRATSen
dc.subjectRATS, WISTARen
dc.subjectSOCIAL BEHAVIORen
dc.subjectSTRESS, PSYCHOLOGICALen
dc.subjectTRYPTOPHAN HYDROXYLASEen
dc.titleAltered Behaviour, Dopamine and Norepinephrine Regulation in Stressed Mice Heterozygous in TPH2 Geneen
dc.typeArticleen
dc.typeinfo:eu-repo/semantics/articleen
dc.typeinfo:eu-repo/semantics/publishedVersionen
dc.identifier.rsi45178652-
dc.identifier.doi10.1016/j.pnpbp.2020.110155-
dc.identifier.scopus85095992892-
local.contributor.employeeStrekalova, T., Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, Netherlands, Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation, Division of Molecular Psychiatry, Centre of Mental Health, University of Würzburg, Würzburg, Germany; Svirin, E., Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, Netherlands, Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation, Division of Molecular Psychiatry, Centre of Mental Health, University of Würzburg, Würzburg, Germany; Waider, J., Division of Molecular Psychiatry, Centre of Mental Health, University of Würzburg, Würzburg, Germany; Gorlova, A., Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, Netherlands, Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation; Cespuglio, R., Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation, Neurocampus Michel Jouvet, VELIB Plateau, Claude-Bernard Lyon-1 University, Lyon, France; Kalueff, A., Laboratory of Cell and Molecular Biology and Neurobiology, Moscow Institute of Physics and Technology, Dolgoprudny, Russian Federation, Institute of Translational Biomedicine, St. Petersburg State, University, St. Petersburg, Russian Federation, Ural Federal University, Ekaterinburg, Russian Federation; Pomytkin, I., Center for Advanced Cell Technologies, Institute of Regenerative Medicine, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation; Schmitt-Boehrer, A.G., Division of Molecular Psychiatry, Centre of Mental Health, University of Würzburg, Würzburg, Germany; Lesch, K.-P., Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, Netherlands, Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation, Division of Molecular Psychiatry, Centre of Mental Health, University of Würzburg, Würzburg, Germany; Anthony, D.C., Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation, Department of Pharmacology, Oxford University, Oxford, United Kingdomen
local.volume108-
dc.identifier.wos000643709100003-
local.contributor.departmentDepartment of Psychiatry and Neuropsychology, Maastricht University, Maastricht, Netherlands; Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation; Division of Molecular Psychiatry, Centre of Mental Health, University of Würzburg, Würzburg, Germany; Neurocampus Michel Jouvet, VELIB Plateau, Claude-Bernard Lyon-1 University, Lyon, France; Laboratory of Cell and Molecular Biology and Neurobiology, Moscow Institute of Physics and Technology, Dolgoprudny, Russian Federation; Institute of Translational Biomedicine, St. Petersburg State, University, St. Petersburg, Russian Federation; Ural Federal University, Ekaterinburg, Russian Federation; Center for Advanced Cell Technologies, Institute of Regenerative Medicine, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation; Department of Pharmacology, Oxford University, Oxford, United Kingdomen
local.identifier.pure21882765-
local.description.order110155-
local.identifier.eid2-s2.0-85095992892-
local.fund.cordisH020: 728018-
local.identifier.wosWOS:000643709100003-
local.identifier.pmid33127424-
Располагается в коллекциях:Научные публикации ученых УрФУ, проиндексированные в SCOPUS и WoS CC

Файлы этого ресурса:
Файл Описание РазмерФормат 
2-s2.0-85095992892.pdf1,71 MBAdobe PDFПросмотреть/Открыть


Все ресурсы в архиве электронных ресурсов защищены авторским правом, все права сохранены.